Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.37
-0.23 (-3.48%)
At close: Aug 11, 2026, 4:00 PM EDT
6.41
+0.04 (0.63%)
After-hours: Aug 11, 2026, 7:59 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $2.24 billion as of August 11, 2026. Its market cap has increased by 184.12% in one year.
Market Cap
2.24B
Enterprise Value
1.99B
1-Year Change
184.12%
Ranking
Category
Stock Price
$6.37
ChartMarket Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $2.24B, an increase of 1,181.91%. That is a compound annual growth rate of 53.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 2.24B | -27.19% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.43B |
| Mineralys Therapeutics | 2.41B |
| Hemab Therapeutics Holdings | 2.33B |
| Harmony Biosciences Holdings | 2.27B |
| Vera Therapeutics | 2.27B |
| UroGen Pharma | 2.26B |
| Rapport Therapeutics | 2.25B |
| Vericel | 2.25B |